This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Oxnard GR, Morris MJ, Hodi FS, Baker LH, Kris MG, Venook AP, et al. When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst. 2012;104:1534–41.
de la Torre-Aláez M, Jordán-Iborra C, Casadei-Gardini A, Bilbao JI, Rodriguez-Fraile M, Sancho L, et al. The pattern of progression defines post-progression survival in patients with hepatocellular carcinoma treated with SIRT. Cardiovasc Interv Radiol. 2020;12:1–8.
Reig M, Rimola J, Torres F, Darnell A, Rodriguez-Lope C, Forner A, et al. Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design. Hepatol. 2013;58:2023–31.
Rincón JO, Regi AR, Leyte MG, Martín LC, Pascual RP, Farto JCA. Hepatic supraselective radioembolization, today and new horizons. Eur J Nucl Med Mol Imaging. 2019;46:2412–3.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nezami, N., Geschwind, J.H. Predicting Patient Survival in Oncology: Is it Time to Take a New Path?. Cardiovasc Intervent Radiol (2020). https://doi.org/10.1007/s00270-020-02553-y